Monash projects backed by Australia's national biotech incub

Biotech projects being led by Monash University have received $2.5M in funding to advance novel therapeutics and preclinical medical research that address schizophrenia, cancer, inflammatory diseases, chronic obstructive pulmonary disease and muscula

Related Keywords

Australia , Monash , South Australia , Kathy Nielsen , Simon Wilkins , Ross Dickins , Chris Langmead , Merlin Thomas , Jonathan Baell , Nadia Kershaw , Gregory Stewart , Peter Currie , Australian Regenerative Medicine Institute Monash University , Eliza Hall Institute , Monash University , Commonwealth Government Medical Research Future Fund , Monash Institute Of Pharmaceutical Sciences , Central Clinical School , Australia National University Prof , Business Development Life Sciences , Ip Group , Monash Investment Holdings , Monash Institute Of Pharmaceutical Sciences Prof , Research Commercialisation Initiative , Central Clinical School Monash University , Professor Chris Langmead , Monash Institute , Professor Peter Currie , Associate Professor Mika , Australian Regenerative Medicine Institute , Associate Professor Ross Dickins , Pharmaceutical Sciences , Australia National University , Phil Board , Professor Merlin Thomas , Central Clinical , Monash Investment , Commonwealth Government , Medical Research Future Fund , Medical Research Commercialisation Initiative , Brandon Biocatalyst , University Chief Commercialisation Officer , Monash Innovation , Business Development , Life Sciences ,